Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Cell|June 15, 2016
Gliomas "Dope Up" for GrowthBrenton R Paolella, Charles D Stiles
Disease Models & Mechanisms|December 25, 2012
Behavioral abnormalities and Parkinson's-like histological changes resulting from Id2 inactivation in miceMatthew C Havrda, Brenton R Paolella, Nora M Ward, et al.
Stem Cells (Dayton, Ohio)|May 25, 2011
p53 directly represses Id2 to inhibit the proliferation of neural progenitor cellsBrenton R Paolella, Matthew C Havrda, Akio Mantani, et al.
Stem Cells (Dayton, Ohio)|January 13, 2016
Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor CellsJaclyn M Sullivan, Matthew C Havrda, Arminja N Kettenbach, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 26, 2008
Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesisMatthew C Havrda, Brent T Harris, Akio Mantani, et al.
Cancer Research|January 16, 2014
Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironmentMatthew C Havrda, Brenton R Paolella, Cong Ran, et al.
ACS Chemical Biology|April 30, 2020
Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic AcidsZeyu Lu, Brenton R Paolella, Nicholas L Truex, et al.
Genome Biology|August 23, 2023
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethalJ Michael Krill-Burger, Joshua M Dempster, Ashir A Borah, et al.
Nature Communications|May 21, 2020
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilitiesCaitlin A Nichols, William J Gibson, Meredith S Brown, et al.
Nature Communications|September 20, 2022
Systematic profiling of conditional degron tag technologies for target validation studiesDaniel P Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, et al.
Pageof 3